<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01222871</url>
  </required_header>
  <id_info>
    <org_study_id>00540</org_study_id>
    <nct_id>NCT01222871</nct_id>
  </id_info>
  <brief_title>Treatment of Early Nasal Polyposis With Topical Triamcinolone</brief_title>
  <official_title>Treatment of Early Nasal Polyposis With Topical Triamcinolone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steward St. Elizabeth's Medical Center of Boston, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Steward St. Elizabeth's Medical Center of Boston, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of intranasal Triamcinolone
      delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked
      dressing, in the treatment and prevention of early nasal polyposis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nasopore, a bio-absorbable nasal dressing, may offer an alternative route of sustained
      steroid drug delivery. The use of topical targeted intranasal steroids may prevent the
      routine adverse effects of oral steroids while maintaining the same therapeutic / clinical
      efficacy.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    not enough particpants
  </why_stopped>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the efficacy of a Nasopore dressing soaked in Triamcinolone verses oral steroids and a saline soaked sponge</measure>
    <time_frame>Three months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone</intervention_name>
    <description>Triamcinolone</description>
    <arm_group_label>single arm</arm_group_label>
    <other_name>Kenalog (40)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone</intervention_name>
    <description>Nasopore Triamcinolone soaked sponge</description>
    <arm_group_label>single arm</arm_group_label>
    <other_name>KENALOG (40)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Patients with early nasal polyposis

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Patients with active sinus infections

          -  Patients on long term steroids

          -  Allergy or sensitivity to steroids

          -  Patients with Antrochoanal polyps

          -  Patients who received topical steroids by bio-resorbable sponge or oral steroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Catalano, MD</last_name>
    <role>Study Director</role>
    <affiliation>Steward St. Elizabeth's Medical Center of Boston, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center, 736 Cambridge St</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2010</study_first_submitted>
  <study_first_submitted_qc>October 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2010</study_first_posted>
  <last_update_submitted>January 2, 2014</last_update_submitted>
  <last_update_submitted_qc>January 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>December 12, 2014</submitted>
    <returned>December 19, 2014</returned>
    <submitted>May 19, 2015</submitted>
    <returned>June 2, 2015</returned>
    <submitted>January 25, 2017</submitted>
    <returned>March 15, 2017</returned>
    <submitted>May 2, 2017</submitted>
    <returned>June 1, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

